Results 131 to 140 of about 40,676 (197)

Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in <i>mdx</i> Mice. [PDF]

Int J Mol Sci
Phongsavanh M, Bizot F, Saoudi A, Gastaldi C, Le Coz O, Tensorer T, Brisebard E, Garcia L, Goyenvalle A.   +8 more
europepmc   +1 more source

Alternative spliceosomal protein Eftud2 mediated Kif3a exon skipping promotes SHH-subgroup medulloblastoma progression. [PDF]

Cell Death Differ
Li Y, Chen L, Xue S, Song Z, Liu H, Li H, Shen W, Zhang C, Wu H.   +8 more
europepmc   +1 more source

Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy. [PDF]

J Muscle Res Cell Motil
Chwalenia K, Wood MJA, Roberts TC.
europepmc   +1 more source

Protocol for using MYOD1-transduced human urine-derived cells as a predictive platform for exon skipping therapy in Duchenne muscular dystrophy. [PDF]

STAR Protoc
Kunitake K, Ishizuka T, Takeshita E, Komaki H, Aoki Y.   +4 more
europepmc   +1 more source

Novel FBN1 intron variant causes isolated ectopia lentis via in-frame exon skipping. [PDF]

J Hum Genet
Shimizu N, Mashimo Y, Yokouchi H, Nishio Y, Sawai S, Ichikawa T, Ogi T, Baba T, Onouchi Y.   +8 more
europepmc   +1 more source

30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon Skipping. [PDF]

Int J Mol Sci
Matsuo M.
europepmc   +1 more source

Gene therapy mediated by exon-skipping in Duchenne muscular dystrophy [PDF]

, 2013
Perelló, C., Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Optimization of Exon-Skipping Riboswitches and Their Applications to Control Mammalian Cell Fate. [PDF]

ACS Synth Biol
Nomura Y, Kim N, Zhu B, Hamzah M, Zhang H, Yokobayashi Y.   +5 more
europepmc   +1 more source

Case Report: a novel variant in <i>WT1</i> leads to focal segmental glomerulosclerosis and uterovaginal anomalies through exon skipping. [PDF]

Front Nephrol
Marquez J, O'Sullivan L, Squire AE, Ryan GL, Debiec KE, Amies Oelschlager AM, Adam MP.   +6 more
europepmc   +1 more source

Antisense-mediated exon skipping targeting EZH2 suppresses tumor growth in a xenograft mouse model of hepatocellular carcinoma. [PDF]

Mol Ther
Bai J, Zhao B, Ma Y, Wang L, Feng P, Hua Y.   +5 more
europepmc   +1 more source